Evidence map›Paper›PMID 35468833›Full record

ArticleBMC research notes2022

Usefulness of a commercial LAMP assay for detection of malaria infection, including Plasmodium knowlesi cases, in returning travelers in Spain.

Alexandra Martín-Ramírez, Marta Lanza, Shamilah Hisam, Ana Perez-Ayala, José M Rubio

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alexandra Martín-RamírezMalaria & Parasitic Emerging Diseases Laboratory, National Microbiology Center, Instituto de Salud Carlos III, Madrid, Spain.
Marta LanzaMalaria & Parasitic Emerging Diseases Laboratory, National Microbiology Center, Instituto de Salud Carlos III, Madrid, Spain.
Shamilah HisamInstitute Medical Research, Parasitology Unit, Kuala Lumpur, Malaysia.
Ana Perez-AyalaDepartment of Clinical Microbiology, Hospital Universitario, 12 de Octubre, Madrid, Spain.
José M RubioMalaria & Parasitic Emerging Diseases Laboratory, National Microbiology Center, Instituto de Salud Carlos III, Madrid, Spain. jmrubio@isciii.es.ORCID http://orcid.org/0000-0002-1903-6711
Instituto de Salud Carlos III · ESHospital Universitario 12 De Octubre · ESInstitute for Medical Research · MY

Funding

Instituto de Salud Carlos III CM17CIII/00012Instituto de Salud Carlos III PI17CIII/00035
6 · The paper itself

Abstract

objectiveMain malaria diagnosis is based on microscopic examination combined with rapid diagnostic tests. Both methods have low sensitivity and specificity. Loop-mediated isothermal amplification techniques have shown a sensitivity similar to PCR but with lower times of performance. This study aimed to assess a commercial LAMP for the diagnosis of malaria (Alethia

resultsOne hundred five samples out of 114 rendered valid results, obtaining 85 positive samples and 18 negative samples with an agreement of 98% compared to the reference method with a sensitivity, specificity and kappa coefficient of 98.84%, 94.74% and 0.94 respectively, with only two discrepant samples. The turnaround time was estimated in 1 h and 30 min, with a cost of 32.67€ per determination. The results showed several advantages of the Alethia

Indexed as

MalariaPlasmodium knowlesiHumansMolecular Diagnostic TechniquesMultiplex Polymerase Chain ReactionNucleic Acid Amplification TechniquesSpainAlethia ® MalariaIllumigene ® MalariaLAMPMalariaMolecular diagnosisPCRPlasmodiumPlasmodium knowlesi

Identifiers

PMID35468833
PMCPMC9036737
OpenAlexW4225247761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.